Mount Sinai Study Finds PTSD May Accelerate Brain Aging in 9/11 Responders
Deep learning brain imaging reveals long-term neurobiological effects of trauma
- Thousands of individuals with the condition are likely undiagnosed.
- Study identifies underutilization of genetic testing as a major contributor to missed diagnoses.
- Findings underscore the growing importance of genetic testing as precision therapies advance toward patients.
Researchers from the Icahn School of Medicine at Mount Sinai have found that post-traumatic stress disorder (PTSD) may be linked to accelerated brain aging among World Trade Center (WTC) responders involved in rescue and recovery operations after the 9/11 terrorist attacks. The study, published in Translational Psychiatry, is the first to apply a deep learning-based brain age model to this population.
The team used BrainAgeNeXt, a cutting-edge artificial intelligence model trained on more than 11,000 MRI scans, to estimate each participant’s “brain age.” They found that WTC responders with PTSD had brains that appeared significantly older than their chronological age compared to those without PTSD. Longer exposure duration at Ground Zero further amplified this effect.
“These findings suggest that PTSD is not only a psychological condition but may also have measurable effects on the brain’s aging process,” said Azzurra Invernizzi, PhD, a postdoctoral fellow in the Department of Environmental Medicine at the Icahn School of Medicine at Mount Sinai and the study’s first author. “Understanding these changes helps us recognize the neurobiological toll of trauma and can guide early interventions to protect brain health.”
The results provide new evidence that the long-term impact of PTSD extends beyond mental health, potentially increasing the risk of age-related neurodegenerative conditions. The study offers a new biomarker—brain age—that could be used to monitor neurological health in trauma-exposed populations. The findings also underscore the importance of continued monitoring and support for WTC responders as they age, and highlight the need for policies that integrate mental and neurological health care for trauma-exposed populations.
“Many 9/11 responders continue to experience the effects of trauma decades later,” said Megan K. Horton, PhD, MPH, Professor of Environmental Medicine at Icahn Mount Sinai and senior author of the study. “By applying advanced neuroimaging tools, we’re uncovering how PTSD and prolonged stress may alter brain structure and function over time. This work is crucial for developing strategies to detect and prevent early signs of cognitive decline.”
The study involved collaboration with researchers from the Renaissance School of Medicine at Stony Brook University. It was funded by the Centers for Disease Control and Prevention/National Institute for Occupational Safety and Health, the National Institute on Aging, the National Institutes of Health, and the Swiss National Science Foundation, among others.
“Mount Sinai has long been at the forefront of caring for World Trade Center responders,” said Michael A. Crane, MD, MPH, Medical Director, World Trade Center Health Program Clinical Center of Excellence at Mount Sinai. “This study exemplifies our commitment to combining neuroscience, environmental health, and advanced computational tools to better understand and address the long-term impacts of trauma.”
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.